James G. Ham
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 Jahre | |
| Ken Bate | M | 73 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 3 Jahre |
| Lamberto Andreotti | M | 73 | 19 Jahre | |
| Paul Howes | M | 69 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | - |
| Manuel Worcel | M | 85 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 19 Jahre |
| Michael Loberg | M | 76 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 27 Jahre |
| Gerald Bruce | M | 68 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 10 Jahre |
| Argeris Karabelas | M | 71 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 4 Jahre |
| Priya Jambhekar | F | - | 3 Jahre | |
| John E. Elicker | M | 64 | 20 Jahre | |
| Jane A. Kramer | F | 68 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 15 Jahre |
| Joseph Squicciarino | M | 67 | 22 Jahre | |
| Fouad Namouni | M | 55 | 21 Jahre | |
| Ittai Harel | M | 56 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 6 Jahre |
| Devang Vallabhdas Kantesaria | M | 51 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 4 Jahre |
| Martin Vogelbaum | M | 60 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 6 Jahre |
| Leif Valdemar Johansson | M | 73 | 13 Jahre | |
| Lewis B. Campbell | M | 77 | 18 Jahre | |
| Laurie Glimcher | M | 72 | 20 Jahre | |
| Brian Daniels | M | 65 | 14 Jahre | |
| Jason Haddock | M | 54 | 14 Jahre | |
| Anthony Hooper | M | 69 | 15 Jahre | |
| Charles Sigal | M | 72 | 16 Jahre | |
| Barry J. Wolfenson | M | 57 | 23 Jahre | |
| Elliott Levy | M | 65 | 17 Jahre | |
| Rebecca Taub | M | 71 | 3 Jahre | |
| Adam Dubow | M | 57 | - | |
| Georgia Keresty | M | 62 | 4 Jahre | |
| Kevin McManus | M | - | 9 Jahre | |
| Lie Ping Chen | M | - | - | |
| Robert Roche | M | 57 | 6 Jahre | |
| Kenneth E. Lebioda | M | - | 5 Jahre | |
| Robert Peach | M | 68 | 9 Jahre | |
| Sharon Real | M | 60 | 3 Jahre | |
| Shu Hui Chen | M | 61 | 5 Jahre | |
| David Cohen | M | - | 8 Jahre | |
| Yadagiri R Pendri | M | 68 | 7 Jahre | |
| Benjamin Winograd | M | 63 | 9 Jahre | |
| David Wishart | M | - | 10 Jahre | |
| Kimberly Gentile | F | 56 | 14 Jahre | |
| Mark Trudeau | M | 62 | 11 Jahre | |
| Samuel Barker | M | 81 | - | |
| Joachim von Roy | M | 79 | - | |
| Dieter Weinand | M | 63 | 9 Jahre | |
| Michael Giordano | M | 66 | 18 Jahre | |
| Ning Yan | M | - | 7 Jahre | |
| James E. Shiah | M | 64 | 3 Jahre | |
| Robert W. Morrissey | M | 66 | 6 Jahre | |
| Douglas C. Plessinger | M | 55 | 6 Jahre | |
| Elizabeth Yamashita | F | - | 6 Jahre | |
| Douglas Hay | M | - | 6 Jahre | |
| Fu-Min Su | M | - | 6 Jahre | |
| Cheryl Capps | F | 62 | 13 Jahre | |
| Lucius Allen | M | - | - | |
| Charles Conway | M | 62 | 17 Jahre | |
| Miguel Forte | M | 63 | 5 Jahre | |
| Larry K. Benedict | M | 63 | 7 Jahre | |
| Laurie Alsup | M | 70 | 10 Jahre | |
| Zola P. Horovitz | M | 89 | - | |
| Alejandro A. Aruffo | M | 63 | 1 Jahre | |
| Peter S. Linsley | M | 72 | 14 Jahre | |
| Robert Francis Doman | M | 74 | 8 Jahre | |
| Daniel M. Bollag | M | 63 | 2 Jahre | |
| Anthony A. McBride | M | 60 | - | |
| Kevin Rooney | M | 58 | 6 Jahre | |
| Michael A. Popson | M | - | 6 Jahre | |
| Timothy McNamara | M | 67 | 9 Jahre | |
| Lisa Kelly-Croswell | F | 57 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 1 Jahre |
| James R. Ellinghausen | M | 65 | 8 Jahre | |
| David L. Zabor | M | 69 | - | |
| Helen Torley | M | 61 | 5 Jahre | |
| Dean Mitchell | M | 68 | 3 Jahre | |
| John L. McGoldrick | M | 83 | 10 Jahre | |
| Stephen E. Bear | M | 73 | 7 Jahre | |
| Steven E. Benner | M | 64 | 7 Jahre | |
| Beth Seidenberg | M | 67 | 2 Jahre | |
| Michael J. Howerton | M | 72 | - | |
| Richard J. White | M | 82 | 12 Jahre | |
| Phillip John Brancazio | M | 71 | 23 Jahre | |
| Stuart Tross | M | 57 | 8 Jahre | |
| Kenneth Anderson | M | - | 17 Jahre | |
| N. Coles | M | 63 | - | |
| Gary Dickinson | M | 72 | 4 Jahre | |
| Peter Kiener | M | 72 | 18 Jahre | |
| Stephen K. Carter | M | 85 | 13 Jahre | |
| Rajesh K. Malik | M | 65 | 2 Jahre | |
| Marino Carol | F | - | 8 Jahre | |
| Robert B. Ross | M | - | 3 Jahre | |
| Andrew Bodnar | M | 75 | - | |
| Mark E. McGovern | M | 70 | 11 Jahre | |
| Ellen Futter | F | 74 | 6 Jahre | |
| Robert L. Simon | M | 79 | 13 Jahre | |
| Walter R. Maupay | M | 84 | - | |
| Daniel Lynch | M | 65 | 15 Jahre | |
| Robert A. Ashley | M | 66 | 5 Jahre | |
| Louis T. DiFazio | M | 86 | 7 Jahre | |
| Nicole Onetto | M | 71 | 6 Jahre | |
| John D. Macomber | M | 96 | 5 Jahre | |
| Stephen Sadove | M | 72 | 10 Jahre | |
| debra j bass | M | - | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- James G. Ham
- Persönliches Netzwerk
